SI

Solesence, Inc. Common Stock

SLSN·NASDAQ

$1.25

-3.5%
Consumer DefensiveHousehold & Personal Products

Solésence, Inc., formerly Nanophase Technologies Corporation, is a developer and manufacturer of clean, inclusive, mineral-based skincare and makeup products. The company partners with global and indie brands, leveraging its proprietary Active Stress Defense™ technology suite to bring environmental protection beauty products to market.

At a Glance

Live Snapshot
Market Cap$88.64M
EPS0.0300
P/E Ratio41.83
Earnings Date08/06/2026
s

Solesence, Inc. Common Stock Street Expectations Map

SLSN · NASDAQ

No Target Data

No analyst price targets available for slsn.

s

Solesence, Inc. Common Stock Forward Estimates of Revenue

SLSN · NASDAQ
Latest Revenue
62.06M
FY 2025
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

s

Solesence, Inc. Common Stock Forward Estimates of Net Income

SLSN · NASDAQ
Latest Net Income
1.79M
FY 2025
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

s

Solesence, Inc. Common Stock Forward Estimates of EPS

SLSN · NASDAQ
Latest EPS
0.03
FY 2025
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

s

Solesence, Inc. Common Stock Forward Estimates of EBIT

SLSN · NASDAQ
Latest EBIT
2.79M
FY 2025
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

s

Solesence, Inc. Common Stock Forward Estimates of EBITDA

SLSN · NASDAQ
Latest EBITDA
3.69M
FY 2025
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

s

Solesence, Inc. Common Stock Forward Estimates of SG&A Expense

SLSN · NASDAQ
Latest SG&A Expense
10.40M
FY 2025
Avg Estimate
N/A
FY N/A
Estimate Range
N/A - N/A
Analyst Spread

Forward Growth Analysis

OutlookCautious

Analyst skepticism evident—carefully evaluate risks before investment decisions.

s

Solesence, Inc. Common Stock Insider Positioning

SLSN · NASDAQ

During the last 12 months, insiders have purchased $11K and sold $210K worth of SLSN shares, resulting in $199K of net selling activity.

3 Months

Bought

0

0.00

Sold

60.0K

210.00K

Net Activity

-210K

-$210K

3-6 Months

Bought

1.0K

1.92K

Sold

0

0.00

Net Activity

+2K

+$2K

6-9 Months

Bought

5.0K

9.45K

Sold

0

0.00

Net Activity

+9K

+$9K

9-12 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

Top Buyers

1
WRJ

Whitmore R Janet

Director

6.0K shares2 transactions

$11K

Top Sellers

1
RLC

Riffner Laura C

Officer: Chief Financial Officer

60.0K shares1 transactions

$210K

Insider Activity Analysis

Net Insider Sentiment

Bearish

Strong bearish signal with $199K net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.

Buy/Sell Ratio

0.05:1

Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.

Recent Trend (3 Months)

$210K

Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.

Insider Participation

Balanced

1 insider buyers and 1 sellers. Equal participation suggests mixed or neutral insider views.

Insider Activity Insight

Persistent selling pressure: Consistent insider selling with weak buy/sell ratio suggests insiders may be capitalizing on current valuation. Exercise caution and review recent earnings quality and management commentary.